Chemistry, pharmacology, and clinical efficacy of the Chinese nootropic agent huperzine A

被引：134

作者：

Kozikowski, AP ^{[1
]}

Tückmantel, W ^{[1
]}

机构：

[1] Georgetown Univ, Inst Cognit & Computat Sci, Drug Discovery Program, Washington, DC 20007 USA

来源：

ACCOUNTS OF CHEMICAL RESEARCH | 1999年 / 32卷 / 08期

关键词：

D O I：

10.1021/ar9800892

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：641 / 650

页数：10

共 61 条

[31] SYNTHESIS OF THE THIAZOLONE ANALOG OF THE ACETYLCHOLINESTERASE INHIBITOR, HUPERZINE-A [J].

KOZIKOWSKI, AP ;

TUCKMANTEL, W ;

SAXENA, A ;

DOCTOR, BP .

HELVETICA CHIMICA ACTA, 1994, 77 (05) :1256-1266

[32] An approach to modified heterocyclic analogues of huperzine A and isohuperzine A. Synthesis of the pyrimidone and pyrazole analogues, and their anticholinesterase activity [J].

Kozikowski, AP ;

Campiani, G ;

Nacci, V ;

Sega, A ;

Saxena, A ;

Doctor, BP .

JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1996, (11) :1287-1297

[33]

KOZIKOWSKI AP, UNPUB

[34]

KOZIKOWSKI AP, 1992, ADV MED CHEM, V1, P175

[35] Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality [J].

Lallement, G ;

Veyret, J ;

Masqueliez, C ;

Aubriot, S ;

Burckhart, MF ;

Baubichon, D .

FUNDAMENTAL & CLINICAL PHARMACOLOGY, 1997, 11 (05) :387-394

[36] CONTRIBUTORY MECHANISMS IN THE CAUSATION OF NEURODEGENERATIVE DISORDERS [J].

LEES, GJ .

NEUROSCIENCE, 1993, 54 (02) :287-322

[37]

Li YL, 1996, CHINESE CHEM LETT, V7, P111

[38] THE STRUCTURES OF HUPERZINE-A AND HUPERZINE-B, 2 NEW ALKALOIDS EXHIBITING MARKED ANTICHOLINESTERASE ACTIVITY [J].

LIU, JS ;

ZHU, YL ;

YU, CM ;

ZHOU, YZ ;

HAN, YY ;

WU, FW ;

QI, BF .

CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1986, 64 (04) :837-839

[39]

Mattson MP, 1998, J NEUROCHEM, V70, P1

[40]

MCKINNEY M, 1997, HERBAL MED NEUROPSYC, P2

← 1 2 3 4 5 6 7 →